Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolfram

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The British Journal of Dermatology|November 13, 2010
Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 miceN L Ward, C M Loyd, J A Wolfram, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
The role of E2F1 in the development of hypertrophic cardiomyopathyJulie A Wolfram, Anna Liner, Sandy L Richardson, et al.
International Journal of Clinical and Experimental Pathology|February 2, 2012
Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditionsCandace M Loyd, Doina Diaconu, Wen Fu, et al.
The American Journal of Physiology|April 1, 1990
A71378: a CCK agonist with high potency and selectivity for CCK-A receptorsC W Lin, M W Holladay, D G Witte, et al.
Molecular Pharmacology|December 1, 1989
Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)C W Lin, M W Holladay, R W Barrett, et al.
Molecular Pharmacology|March 1, 1991
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptorsC W Lin, K Shiosaki, T R Miller, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 25, 2009
Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomaliesJamie Wikenheiser, Julie A Wolfram, Madhusudhana Gargesha, et al.
The American Journal of Pathology|April 4, 2009
Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasisJulie A Wolfram, Doina Diaconu, Denise A Hatala, et al.
Journal of Molecular and Cellular Cardiology|February 25, 2017
BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractilityMonte S Willis, Darcy Wood Holley, Zhongjing Wang, et al.
Current Alzheimer Research|March 7, 2014
Accumulation of intraneuronal amyloid-β is common in normal brainJeffrey A Blair, Sandra L Siedlak, Julie A Wolfram, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|November 13, 2010
Depletion of antigen-presenting cells by clodronate liposomes reverses the psoriatic skin phenotype in KC-Tie2 miceN L Ward, C M Loyd, J A Wolfram, et al.
International Journal of Clinical and Experimental Pathology|July 9, 2011
The role of E2F1 in the development of hypertrophic cardiomyopathyJulie A Wolfram, Anna Liner, Sandy L Richardson, et al.
International Journal of Clinical and Experimental Pathology|February 2, 2012
Transgenic overexpression of keratinocyte-specific VEGF and Ang1 in combination promotes wound healing under nondiabetic but not diabetic conditionsCandace M Loyd, Doina Diaconu, Wen Fu, et al.
The American Journal of Physiology|April 1, 1990
A71378: a CCK agonist with high potency and selectivity for CCK-A receptorsC W Lin, M W Holladay, D G Witte, et al.
Molecular Pharmacology|December 1, 1989
Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33)C W Lin, M W Holladay, R W Barrett, et al.
Molecular Pharmacology|March 1, 1991
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptorsC W Lin, K Shiosaki, T R Miller, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 25, 2009
Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomaliesJamie Wikenheiser, Julie A Wolfram, Madhusudhana Gargesha, et al.
The American Journal of Pathology|April 4, 2009
Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasisJulie A Wolfram, Doina Diaconu, Denise A Hatala, et al.
Journal of Molecular and Cellular Cardiology|February 25, 2017
BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractilityMonte S Willis, Darcy Wood Holley, Zhongjing Wang, et al.
Current Alzheimer Research|March 7, 2014
Accumulation of intraneuronal amyloid-β is common in normal brainJeffrey A Blair, Sandra L Siedlak, Julie A Wolfram, et al.
Pageof 3